Hydroxychloroquine as antiviral prophylaxis for exposed caregivers to Covid-19: An urgent appraisal is needed
Background: Since the onset of the new coronavirus pandemic, the world is facing a public health emergency. Repositioning hydroxychloroquine (HQ) seems to be a promising option. Many emerging evidences have converged on the effectiveness of HQ in the treatment of Covid-19 infection. In a recent pape...
Main Authors: | Rachid Tahiri Joutei Hassani, Ahmed Bennis |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-06-01
|
Series: | Journal of Infection and Public Health |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1876034120304718 |
Similar Items
-
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?
by: Praveen Balabaskaran Nina, et al.
Published: (2020-01-01) -
Hydroxychloroquine and chloroquine in prophylaxis and treatment of COVID-19: What is known?
by: Pathiyil Ravi Shankar, et al.
Published: (2021-01-01) -
Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19
by: Tzu-Chuan Ho, et al.
Published: (2021-02-01) -
The continued dilemma about the usage of hydroxychloroquine: Respite is in randomized control trials
by: Amit Malviya
Published: (2020-10-01) -
Should chloroquine and hydroxychloroquine be used to treat COVID-19? A rapid review
by: Kome Gbinigie, et al.
Published: (2020-04-01)